Literature DB >> 10652999

Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes.

J G Rosmalen1, T Martin, C Dobbs, J S Voerman, H A Drexhage, K Haskins, P J Leenen.   

Abstract

Islet-specific T cells are essential in the development of type I diabetes. The role of non-lymphoid cells is relatively unclear, although infiltration of dendritic cells and macrophages is the first sign of islet autoimmunity in diabetes-prone nonobese diabetic (NOD) mice. BDC2.5 is one of the autoreactive T cell clones isolated from NOD mice. Transfer of BDC2.5 T cells into young NOD mice accelerates diabetes development, whereas transgenic expression of the BDC2.5 T cell receptor on NOD T cells (BDC2.5 TCR-Tg NOD) markedly reduces diabetes development. We show that, although the same antigen-specificity is involved, both models differ significantly in insulitis. BDC2.5 TCR-Tg NOD mice develop an extensive, but non-aggressive, peri-insulitis by 3 weeks of age. In these large peri-islet infiltrates, resembling secondary lymphoid tissue, BM8+ macrophages (Mphi) are virtually absent. In contrast, BDC2.5 T cell clone transfer results in an aggressive insulitis with small infiltrates, but relatively large numbers of BM8 Mphi. Infiltration of BM8+ Mphi therefore correlates with islet destruction. This is, however, not observed for all Mphi; Monts-4+ Mphi follow a reverse pattern and are present in higher numbers in BDC2.5 TCR-Tg than in transferred mice. ER-MP23+ Mphi are reduced in both transferred and transgenic mice compared with wild-type NOD. Thus, this study underlines and extends previous data suggesting that Mphi are implicated in both early and late phases in diabetes development. Furthermore, our data imply that subsets of non-lymphoid cells have different roles in diabetes development. It is, therefore, important to recognize this heterogeneity when interpreting both in vivo and in vitro studies concerning non-lymphoid cells in diabetes.

Entities:  

Mesh:

Year:  2000        PMID: 10652999     DOI: 10.1038/labinvest.3780004

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

Review 1.  Neuronal elements in the pathogenesis of type 1 diabetes.

Authors:  Hubert Tsui; Shawn Winer; George Jakowsky; H-Michael Dosch
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model.

Authors:  Boris Calderon; Anish Suri; Emil R Unanue
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

3.  Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice.

Authors:  Maria C Seleme; Weiqi Lei; Ashley R Burg; Kah Yong Goh; Allison Metz; Chad Steele; Hubert M Tse
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

4.  Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes.

Authors:  Yan Bai; Elizabeth Robinson; Ryan Chai; Jacqueline M Ross; Shiva Reddy
Journal:  J Mol Histol       Date:  2006-07-29       Impact factor: 2.611

5.  Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.

Authors:  C Gysemans; E Van Etten; L Overbergh; A Verstuyf; M Waer; R Bouillon; C Mathieu
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

6.  Lymphocytic insulitis in a juvenile dog with diabetes mellitus.

Authors:  G Jouvion; J Abadie; J M Bach; F Roux; J Miclard; J Y Deschamps; L Guigand; P Saï; M Wyers
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

7.  Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice.

Authors:  A Giulietti; C Gysemans; K Stoffels; E van Etten; B Decallonne; L Overbergh; R Bouillon; C Mathieu
Journal:  Diabetologia       Date:  2004-01-31       Impact factor: 10.122

8.  Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.

Authors:  Marcia McDuffie; Nelly A Maybee; Susanna R Keller; Brian K Stevens; James C Garmey; Margaret A Morris; Elizabeth Kropf; Claudia Rival; Kaiwen Ma; Jeffrey D Carter; Sarah A Tersey; Craig S Nunemaker; Jerry L Nadler
Journal:  Diabetes       Date:  2007-10-16       Impact factor: 9.461

9.  Imaging inflammation of the pancreatic islets in type 1 diabetes.

Authors:  Maria C Denis; Umar Mahmood; Christophe Benoist; Diane Mathis; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-10       Impact factor: 11.205

Review 10.  HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes.

Authors:  Shu Zhang; Jixin Zhong; Ping Yang; Feili Gong; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2009-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.